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Abstract 
The evidence base for vaccine hesitancy communication is generally confined to research 
focused on the content of the message rather than the process of communication. This has 
important consequences, because shifting focus to encompass the process of communicating, and 
not just on the content of content message being conveyed; opens the possibility of greater 
insight and understanding regarding the conversation health care workers have with those who 
are vaccine hesitant, creating increased chances of acceptance. 
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1. Introduction
The increase in vaccine hesitancy over the past few years is a peculiar phenomenon. A growing 
number of people are delaying or putting off vaccination for themselves and/or their children due 
to concerns that are not founded on science or even general historical experience. While most 
people automatically accept the physician’s suggestion (or announcement) of vaccination, many 
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people in developed countries, including several with high levels of education, are not accepting 
vaccination despite the prevailing evidence of the benefits [1]. While the causes are varied and 
complex, one of the key issues concerns what counts as evidence of value and efficacy regarding 
vaccination for the person who expresses hesitancy. For some, the anecdote or the celebrity 
statement is of greater value than the research cited by their physician. We can disagree with a 
position predicated on such evidence, but what we cannot escape is that what counts as evidence 
is a choice we make in any situation, even as scientists or physicians, and it certainly impacts the 
choices made in vaccine hesitancy. 
What counts as evidence in the support of a position or practice is a critical part of decision 
making. This is definitely the case in an era where the concept of “evidence based medicine” 
plays a defining role in determining acceptable, much less best practices, in medical care. 
Procedures, such as the Grading of Recommendations, Assessment, Development, and 
Evaluation (GRADE) method, have been developed to assess evidence in an effort to consider 
not only what counts as evidence but also what is the level of confidence one should place in the 
evidence at hand. Not surprisingly, those who have developed mechanisms such as GRADE 
consider the randomized controlled trial to be the gold standard for considering the quality of 
evidence in support of a conclusion regarding the principle, practice, or procedure being 
evaluated. This works well when the focus of evaluation is clear (e.g. the efficacy of a drug or 
vaccine). However, it becomes more problematic if the focus is something less clear, such as 
communication. 
As Waisbord [2], Craig [3,4], and others have noted, the definition of communication is not a 
clear concept or activity, nor does everyone agree on a definition, theory, or meta theory of what 
it is and how it works. Depending on how one defines communication, the question of what 
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counts as evidence can change dramatically. Many in health operate with the notion that 
communication is primarily a vehicle for the conveyance of information. The measure of 
communication quality is focused on clarity, completeness, and timeliness of information 
delivered. Thus the focus is almost solely on the content of the messages. Evidence for the 
effectiveness of communication is collected by both reach, recall, or perceived impact of a 
message that has been conveyed whether by media or in face-to-face situations such as a clinical 
setting. This data can tell us if people took in a message and can repeat it. However, in these 
circumstances, no matter what measures we choose, the focus is on the content of the 
communication and not the process itself. 
Evidence of good process, however, is not the same thing as evidence of good content. Well-
conceived messages, delivered poorly, may not have as much impact as poorly constructed 
messages delivered well. In other words, how we say something is often at least as important if 
not more important, than what we say. When we consider making evidence based decisions for 
patient provider interactions focused on vaccination, the process of the conversation should be 
our focus, not simply message content. More importantly, what we say occurs in the context of a 
conversation, not as a message standing alone, unfettered by the context of interaction between 
the parties. The process of conversation is where vaccine hesitancy will be addressed, not in a 
singular message that stunningly persuades a person to shift to acceptance. 
However, quite often, studies that lead to the extant evidence base for vaccine hesitancy 
communication, are concerned with what is said and substantially ignores the way in which it is 
said or the context of the conversation in which it occurs [5]. This is not without value, but 
misses much of what is important when circumstances become more challenging, such as in the 
face of hesitancy. Thus, while we find good evidence for the approach to patients that focuses on 
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the announcement (and therefore is assumptive) that today vaccination will take place, we have 
little in the way of evidence that indicates how this (and the rest of the conversation) should be 
conducted, especially if the person is hesitant or resistant. For this we must turn to research 
focused on the communication process irrespective of the content of the messaging. 
A large and growing number of theorists and researchers in communication, complexity, and 
neuroscience, along with others exploring a quantum basis for social science explanations of 
human action, are adding depth to our understanding of the process nature of communication and 
the value of focusing more on conversation than on the content of a specific message [6,7]. 
While people process information in a rational, analytical way, they also interact and make 
decisions based on how they feel, even if their response is not consistent with the content of the 
message. For too long we have theorized and researched concepts such as risk and trust, key 
aspects of vaccine hesitancy, as if they were reasoned action or part of a health belief system 
without considering that they may be a manifestation of an intuitive feeling, part of an implicit 
memory, or based on an alternative domain of evidence that they accept as superior to the 
judgment of their health care professional (HCP) or the body of science that they offer as support 
of the reason to vaccinate. 
Although a number of studies address the complex issues associated with communication 
between people, most of this research has not specifically centered on vaccine hesitancy. As a 
consequence, even though such research could inform HCPs regarding the conversational 
process with vaccine hesitant patients, it is often not considered because it is not content specific 
to the issue at hand. When content is considered without regard to the process of communication 
then such a criterion is reasonable. However, when the other aspects of interaction are the focus 
of analysis, and not simply the message content, then the rationale for excluding other research is 
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less viable. This is not to say that research focused on the conversational process of vaccine 
hesitant-HCP interactions should not be conducted, but rather that evidence derived from 
conversation based research, especially on how trust and risk evolve in the flow, might serve as 
well as message based studies as guidance for practice. 
For example, research has been done to support the notion that people are not as receptive to 
information when they are in a reactive of defensive state rather than a receptive frame of 
mind [8,9] When the amygdala is activated, which can happen when people feel they are in a 
potentially adversarial conversation, then information is processed differently than when this is 
not the case. Further, some research suggests ways of interacting with people that can increase 
receptivity, irrespective of the specific issue, potentially setting the stage for the amelioration of 
hesitancy. In turn, if the HCP escalates the reactivity of the patient, then the hesitancy could 
move to resistance, making the efforts to increase vaccine uptake that much more difficult. 
Although this research has not specifically been conducted on vaccine hesitancy communication, 
there is little reason to believe that it does not apply to such conversations. 
Just as we would have those experiencing vaccine hesitancy look at the best available science to 
make their decisions, so should HCPs regarding the evidence of communication. Focusing on the 
content of the message as if information is the only dimension of communication diverts 
attention from research that may well serve HCPs better as they attempt to develop the 
wherewithal to address the vaccine hesitant person in their offices, clinics, and communities. 
Evidence for communication efficacy is not simply about the content of the message, nor is it 
only about information and how it is analyzed as a basis for making choices. Perhaps this is why 
meta-analysis of research using the Theory of Reasoned Action finds that it typically accounts 
for only 27% of the variance [10]. Attitudes and beliefs are important in communication as well 
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as decision-making, but they are not the only aspects of this process. So are intuitive feelings, 
implicit as well as explicit memories, and emotions. As a process, communication is more than 
message content; it is a range of interchanges, such that each party influences the flow, shaping 
what the other says. If we only count as evidence, message content about vaccines, then we miss 
examining evidence that could prove vital in addressing the problem of vaccine hesitancy. The 
narrow definition of communication that has dominated research in health and medical decision-
making has led to an under consideration of evidence that could make a major difference in the 
management of the vaccine hesitancy phenomenon. 
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